The Effect of co-administration Tamoxifen and Jaeumkanghwa-tang extract on Endometrium of Breast cancer patients
- Conditions
- Neoplasms
- Registration Number
- KCT0002030
- Lead Sponsor
- Comprehensive & Integrative Medicine Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 14
1. Breast cancer patients taking tamoxifen more then 6 month with postmenopausal.
2. The ECOG (eastern cooperative oncology group) performance scale 0-2
3. Age: 25-75
4. No disability of cognitive function
5. Patietns who can be possible to follow up during the study
6. Patients whe have signed an approved informed consent
1. Patients who receive alternative therapy for treatment endometral symptoms.
2. Patients who have a history of hypersensitivity after taking Jaumganghwa-tang granuales.
3. Patients who reveive therapy for treatment gynecological diseases such as endometral cancer, ovarian cancer, endometrial hyperplasia etc.
4. Severe liver or kidney failure at liver and kidney function test.
5. Patients who are not suitable for this study.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method size and shape of polyps; color of cervix with hysteroscopic;the range or amount of fluid accumulation ; the size and number of cyst
- Secondary Outcome Measures
Name Time Method vaginal bleeding, vaginal secretions with questionnaires.;blood and hormone test